Cancer Research Targets  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geissinger, E.
Right arrow Articles by Wellbrock, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geissinger, E.
Right arrow Articles by Wellbrock, C.
[Cancer Research 62, 4820-4828, August 15, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

Autocrine Stimulation by Osteopontin Contributes to Antiapoptotic Signalling of Melanocytes in Dermal Collagen1

Eva Geissinger2, Christin Weisser, Petra Fischer, Manfred Schartl and Claudia Wellbrock3

Department of Physiological Chemistry I, Biocenter (Theodor-Boveri Institut), University of Würzburg, Am Hubland, 97074 Würzburg, Germany

The growth of melanocytes, the pigment-producing cells of the skin, normally is restricted to the epidermis. Transformed melanocytes, which have invaded the dermis, however, have gained the ability to grow in this new environment and to counteract apoptosis induced by the dermal connective tissue. The expression of genes contributing to the survival of melanocytes in the dermal environment, therefore, might be involved in melanoma development. Using a differential display approach, we identified osteopontin as such a gene. In melanocytes, expression of the secreted adhesion protein OPN was up-regulated by the melanoma-inducing receptor tyrosine kinase Xmrk as well as by the fibroblast growth factor receptor, which plays a decisive role in human melanoma. Activation of both receptors triggered survival of melanocytes in three-dimensional dermal collagen gels. Competition experiments revealed that the presence of OPN in the medium as a result of receptor signaling was contributing to these effects. Addition of exogenous OPN allowed melanocytes to adhere, spread, and survive in three-dimensional collagen gels, whereas in the absence of OPN, the cells underwent apoptosis. The integrin {alpha}vß3 known to be involved in melanoma cell survival and growth was identified as an OPN receptor, which points to an OPN-mediated cross-talk between growth factor receptors and this integrin receptor in melanocytes. In summary, we could show that in melanocytes growth factor receptor-induced secretion of OPN can promote antiapoptotic signaling and mediate appropriate interactions with the extracellular matrix in an autocrine way. Our findings suggest a new role of growth factor receptors of the family of receptor tyrosine kinases in processes associated with melanoma development and progression.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
G. Song, Y. Ming, Y. Mao, S. Bao, and G. Ouyang
Osteopontin Prevents Curcumin-Induced Apoptosis and Promotes Survival Through Akt Activation via {alpha}v{beta}3 Integrins in Human Gastric Cancer Cells
Experimental Biology and Medicine, December 1, 2008; 233(12): 1537 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
H. L. Winfield, F. Kirkland, F. I. Ramos-Ceballos, and T. D. Horn
Osteopontin Expression in Spitz Nevi
Arch Dermatol, August 1, 2007; 143(8): 1076 - 1077.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. H. Burdo, M. R. Wood, and H. S. Fox
Osteopontin prevents monocyte recirculation and apoptosis
J. Leukoc. Biol., June 1, 2007; 81(6): 1504 - 1511.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. R. Alonso, L. Tracey, P. Ortiz, B. Perez-Gomez, J. Palacios, M. Pollan, J. Linares, S. Serrano, A. I. Saez-Castillo, L. Sanchez, et al.
A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis
Cancer Res., April 1, 2007; 67(7): 3450 - 3460.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
O. Larsson, D. M. Perlman, D. Fan, C. S. Reilly, M. Peterson, C. Dahlgren, Z. Liang, S. Li, V. A. Polunovsky, C. Wahlestedt, et al.
Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure
Nucleic Acids Res., September 11, 2006; 34(16): 4375 - 4386.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Packer, S. Pavey, A. Parker, M. Stark, P. Johansson, B. Clarke, P. Pollock, M. Ringner, and N. Hayward
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN
Carcinogenesis, September 1, 2006; 27(9): 1778 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-H. Hsieh, M. M. Juliana, P. H. Hicks, G. Feng, C. Elmets, L. Liaw, and P.-L. Chang
Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Cancer Res., July 15, 2006; 66(14): 7119 - 7127.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Meierjohann, E. Wende, A. Kraiss, C. Wellbrock, and M. Schartl
The oncogenic epidermal growth factor receptor variant xiphophorus melanoma receptor kinase induces motility in melanocytes by modulation of focal adhesions.
Cancer Res., March 15, 2006; 66(6): 3145 - 3152.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Guarino, P. Faviana, G. Salvatore, M. D. Castellone, A. M. Cirafici, V. De Falco, A. Celetti, R. Giannini, F. Basolo, R. M. Melillo, et al.
Osteopontin Is Overexpressed in Human Papillary Thyroid Carcinomas and Enhances Thyroid Carcinoma Cell Invasiveness
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5270 - 5278.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
W. Bao and S. Stromblad
Integrin {alpha}v-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen
J. Cell Biol., November 22, 2004; 167(4): 745 - 756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Zohar, B. Zhu, P. Liu, J. Sodek, and C. A. McCulloch
Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1730 - H1739.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P.-L. Chang, M. Cao, and P. Hicks
Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells
Carcinogenesis, November 1, 2003; 24(11): 1749 - 1758.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. A. Furger, A. L. Allan, S. M. Wilson, C. Hota, S. A. Vantyghem, C. O. Postenka, W. Al-Katib, A. F. Chambers, and A. B. Tuck
{beta}3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin
Mol. Cancer Res., September 1, 2003; 1(11): 810 - 819.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Chen, I. Yang, R. Irby, K. H. Shain, H. G. Wang, J. Quackenbush, D. Coppola, J. Q. Cheng, and T. J. Yeatman
Regulation of Caspase Expression and Apoptosis by Adenomatous Polyposis Coli
Cancer Res., August 1, 2003; 63(15): 4368 - 4374.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.